Yew Bio-Pharm Group, Inc.
YEWB · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $14 | $20 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $15 | $9 |
| Total Curr. Assets | $14 | $21 | $16 | $10 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $46 | $41 | $41 | $42 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $4 | $6 |
| Total NC Assets | $47 | $43 | $46 | $48 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $61 | $63 | $62 | $58 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $0 |
| Short-Term Debt | $9 | $9 | $9 | $9 |
| Tax Payable | $1 | $0 | $0 | $1 |
| Deferred Revenue | $2 | $1 | $1 | $0 |
| Other Curr. Liab. | -$1 | $1 | $1 | $0 |
| Total Curr. Liab. | $13 | $13 | $12 | $11 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $1 | $1 | $1 |
| Total NC Liab. | $2 | $1 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $15 | $14 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $32 | $34 | $34 | $31 |
| AOCI | $1 | $1 | $0 | $4 |
| Other Equity | $13 | $13 | $13 | $14 |
| Total Equity | $47 | $48 | $48 | $45 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | $0 |
| Total Liab. & Tot. Equity | $61 | $63 | $62 | $58 |
| Net Debt | $9 | $9 | $9 | $8 |